Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Massachusetts General Hospital
Boston, Massachusetts, United States
Jennifer Temel, MDJoseph Greer, PhDRecruiting - Duke University
Durham, North Carolina, United States
Thomas Leblanc, MDRecruiting - University of Pennsylvania
Philadelphia, Pennsylvania, United States
Pallavi Kumar, MD, MPHRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2025
- Primary completion
- 1 Oct 2029
- Completion
- 31 Mar 2030
- Last update posted
- 18 Nov 2025
- Registered enrollment
- 400
- Registry id
- NCT06795529
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.